Screener
Neurocrine Biosciences NBIX Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
| (dollars in millions) | Operating Leases | Sublease Income |
|---|---|---|
| 2029 | 59.8 | (3.6) |
| 2030 | 60.7 | (3.5) |
| Thereafter | 306.9 | (2.0) |
| Total operating lease payments (sublease income) | 590.2 | $(20.1) |
| Less imputed interest | 126.7 | |
| Total operating lease liabilities | 463.5 | |
| Less current operating lease liabilities included in other current liabilities | 57.3 | |
| Noncurrent operating lease liabilities | $406.2 |
Item 1. Financial Statements
FAQ
- What is Neurocrine Biosciences's operating lease liabilities (total)?
- Neurocrine Biosciences (NBIX) reported operating lease liabilities (total) of $463.5M in Q1 2026.
- How has Neurocrine Biosciences's operating lease liabilities (total) changed year-over-year?
- Neurocrine Biosciences's operating lease liabilities (total) decreased by 6.0% year-over-year, from $493.1M to $463.5M.
- What is the long-term trend for Neurocrine Biosciences's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's operating lease liabilities (total) has grown at a 35.1% compound annual growth rate (CAGR), from $104.7M to $471.3M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Neurocrine Biosciences's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude